A poll of registered voters, conducted by Morning Consult and commissioned by NACDS, includes findings that can help make the case for direct and indirect remuneration (DIR) fee relief, and for broader reimbursement issues.
As HHS’ Azar Testifies, NACDS Urges His DIR Reform Proposals NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement
NACDS’ Congressional statement keys on lowering patients’ costs at pharmacy counter, reducing overall healthcare costs, and fostering pharmacy viability by preventing below-cost reimbursement.
"On social media, we saw a photo of NACDS Board of Directors member Richard Ashworth, president, operations, Walgreen Co., at a white board in the office of U.S. Sen. Bill Cassidy (R-LA), literally drawing out an example for the Senator that demonstrates the need for fair pharmacy reimbursement, for transparency in the prescription drug supply chain, and for appropriate pharmacy metrics that should be tethered to DIR fee reform."
NACDS Urges DIR Fee Reform in Morning Consult Op-Ed NACDS President & CEO Steven C. Anderson emphasizes DIR fee reform’s role in lowering patients’ out of pocket costs, reducing overall healthcare costs
Morning Consult today published an opinion piece by the NACDS entitled “DIR Fee Reform: Lining Up Another Win for Patients on Drug Costs.”
Inside–the–Beltway publications will send a strong message next week: Pharmacy stands as a trusted source of cost–reducing policy strategies, and DIR fee reform tops the agenda.
NACDS and NCPA held a briefing this week on DIR fee reform for the Congressional Doctors Caucus. The Caucus is comprised of 16 medical providers in Congress who use their medical expertise to develop patient-centered healthcare policy.
Rep. Cathy McMorris Rodgers (R-WA), a consistently pro-pharmacy advocate, led a letter to Health and Human Services Secretary Alex Azar urging support for DIR fee reform.
NACDS Urges DIR Fee Reform in Statement to House Ways and Means Committee Details opportunities to reduce patients’ out-of-pocket drug costs and to lower overall healthcare spending through DIR fee reform; Describes public’s trust of pharmacies’ cost-saving proposals
NACDS today submitted a statement to the U.S. House of Representatives Committee on Ways and Means for the hearing titled “The Cost of Rising Prescription Drug Prices.”
NACDS, NCPA Thank Patient, Consumer Groups for Taking Important Stance on DIR Fee Reform Groups emphasize DIR fee reform’s power to reduce out-of-pocket drug costs and to reduce overall healthcare costs as a result of medication adherence and better health
NACDS and the National Community Pharmacists Association (NCPA) today lauded 24 patient and consumer groups for advocating for pharmacy direct and indirect remuneration (DIR) fee reform.
NACDS, NCPA Praise Senate Action to Reduce Patient Drug Costs Bipartisan Senate letter to HHS Secretary urges swift action on pharmacy DIR fee reform to lower out-of-pocket drug costs for patients and to stop unworkable practices that are unfair to pharmacies
NACDS and the National Community Pharmacists Association (NCPA) today praised a bipartisan Senate letter to Health and Human Services Secretary Alex Azar.